他汀类药物在脑卒中预防研究中的临床证据

被引：14

作者：

张茁

机构：

[1] 首都医科大学附属北京安贞医院神经内科

来源：

中华老年心脑血管病杂志 | 2007年 / 10期

关键词：

抗胆固醇血症药; 脑血管意外;

D O I：

暂无

中图分类号：

R743.3 [急性脑血管疾病（中风）];

学科分类号：

1002 ;

摘要：

引用

页码：649 / 651

页数：3

共 5 条

[1] 稳定型冠心病患者阿托伐他汀强化降脂治疗的作用 [J].

LaRosa J. C. ;

Grundy S. M. ;

Waters D. D. ;

张宪伟 .

世界核心医学期刊文摘(心脏病学分册), 2005, (11) :30-31

[2]

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial[J] . The Lancet . 2003 (9364)

[3]

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial[J] . James Shepherd,Gerard J Blauw,Michael B Murphy,Edward LEM Bollen,Brendan M Buckley,Stuart M Cobbe,Ian Ford,Allan Gaw,Michael Hyland,J Wouter Jukema,Adriaan M Kamper,Peter W Macfarlane,A Edo Meinders,John Norrie,Chris J Packard,Ivan J Perry,David J Stott,Brian J Sweeney,Gillian Twomey,Rudi GJ Westendorp.The Lancet . 2002 (9346)

[4]

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial[J] . The Lancet . 2002 (9326)

[5]

Cardiovascular Events and Their Reduction With Pravastatin in Diabetic and Glucose-Intolerant Myocardial Infarction Survivors With Average Cholesterol Levels: Subgroup Analyses in the Cholesterol And Recurrent Events (CARE) Trial[J] . Ronald B. Goldberg,Margot J. Mellies,Frank M. Sacks,Lemuel A. Moye,Barbara V. Howard,William James Howard,Barry R. Davis,Thomas G. Cole,Marc A. Pfeffer,Eugene Braunwald.Circulation . 1998 (23)

← 1 →